0000905148-24-001095.txt : 20240403
0000905148-24-001095.hdr.sgml : 20240403
20240403215432
ACCESSION NUMBER: 0000905148-24-001095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edmondson Frazor Titus III
CENTRAL INDEX KEY: 0001835780
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38205
FILM NUMBER: 24821475
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD, BLDG. 1, FOURTH FLOOR
STREET 2: PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zai Lab Ltd
CENTRAL INDEX KEY: 0001704292
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
BUSINESS PHONE: 862161632588
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
4
1
form4.xml
X0508
4
2024-04-01
0001704292
Zai Lab Ltd
ZLAB
0001835780
Edmondson Frazor Titus III
C/O ZAI LAB LIMITED
314 MAIN STREET, 4TH FLOOR, SUITE 100
CAMBRIDGE
MA
02142
true
Chief Legal Officer
false
American Depositary Shares
2024-04-01
4
M
0
2671
16.72
A
22676
D
American Depositary Shares
2024-04-01
4
M
0
830
16.72
A
23506
D
American Depositary Shares
2024-04-02
4
S
0
675
16.151
D
22831
D
American Depositary Shares
2024-04-02
4
S
0
210
16.151
D
22621
D
Stock Options (Right to Buy)
16.72
2024-04-01
4
A
0
84663
0
A
2034-04-01
American Depositary Shares
84663
84663
D
Restricted Share Units
2024-04-01
4
A
0
55031
0
A
American Depositary Shares
55031
55031
D
Restricted Share Units
2024-04-01
4
M
0
2671
0
D
American Depositary Shares
2671
8013
D
Restricted Share Units
2024-04-01
4
M
0
830
0
D
American Depositary Shares
830
1660
D
Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
ADSs acquired on vesting of Restricted Share Units.
These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units.
Each Stock Option is exercisable for one ADS, which represents ten Ordinary Shares of the issuer.
The option vests in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service.
Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting.
The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
/s/ Bruce Blefeld, Attorney-in-Fact
2024-04-03